InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,762.48
(
0.42%
)
US TECH 100
19,499.20
(
0.15%
)
Dow Jones
42,330.15
(
0.04%
)
Brent Oil
71.79
(
-0.28%
)
Bitcoin
63,308.50
(
-0.03%
)
Post# of 253261
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Robert C Jonson

Send PM Follow Ignore
Followers 29
Posts 2137
Boards Moderated 0
Alias Born 10/28/2007

Robert C Jonson

Re: ThomasS post# 76241

Monday, 04/20/2009 8:25:55 AM

Monday, April 20, 2009 8:25:55 AM

Post# of 253261
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
<a href=http://http://ir.peregrineinc.com/releaseDetail.cfm?ReleaseID=378060
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up